市場調査レポート

商品コード

1126198

世界の希少疾患遺伝子検査市場：考察と予測 (2028年まで)

Global Rare Disease Genetic Testing Market Insights, Forecast to 2028

出版日: 2022年09月20日 | 発行: QYResearch

| ページ情報: 英文 119 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,900 768,124円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 7,350 1,152,186円

レポートPDFを5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 9,800 1,536,248円

レポートPDFを企業内すべての方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

当レポートは、希少疾患遺伝子検査 (Rare Disease Genetic Testing) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

調査範囲
市場分析：タイプ別
- 世界の希少疾患遺伝子検査の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
- Next-Generation Sequencing (NGS)
- Array Technology
- PCR-based Testing
- Fluorescence in Situ Hybridization (FISH)
- Sanger Sequencing
- Karyotyping
- Others
市場：アプリケーション別
- 世界の希少疾患遺伝子検査の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
- Research Laboratories and CROs
- Diagnostic Laboratories
- Hospitals and Clinics
- Others
調査目的
対象期間

第2章世界の市場成長トレンド

世界の希少疾患遺伝子検査の市場展望 (2017-2028)
希少疾患遺伝子検査の市場成長トレンド：地域別
- 希少疾患遺伝子検査市場規模：地域別: 2017 VS 2021 VS 2028
- 希少疾患遺伝子検査の市場規模実績：地域別 (2017-2022)
- 希少疾患遺伝子検査の市場規模予測：地域別 (2023-2028)
希少疾患遺伝子検査市場動向
- 希少疾患遺伝子検査業界動向
- 希少疾患遺伝子検査市場の促進要因
- 希少疾患遺伝子検査市場の課題
- 希少疾患遺伝子検査市場の抑制要因

第3章競合情勢：主要企業別

世界の希少疾患遺伝子検査の上位企業：収益別
- 世界の希少疾患遺伝子検査の上位企業：収益別 (2017-2022)
- 世界の希少疾患遺伝子検査の収益シェア：企業別 (2017-2022)
世界の希少疾患遺伝子検査の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
企業ランキング：希少疾患遺伝子検査の収益
世界の希少疾患遺伝子検査市場集中度
- 世界の希少疾患遺伝子検査市場集中度 (CR5 and HHI)
- 世界の上位10・上位5企業：希少疾患遺伝子検査の収益 2021
希少疾患遺伝子検査の主要企業の本社および事業エリア
主要企業希少疾患遺伝子検査の製品ソリューションおよびサービス
市場参入時期：希少疾患遺伝子検査市場
M&A, 拡張計画

第4章希少疾患遺伝子検査内訳データ：タイプ別

世界の希少疾患遺伝子検査の市場規模実績：タイプ別 (2017-2022)
世界の希少疾患遺伝子検査の市場規模予測：タイプ別 (2023-2028)

第5章希少疾患遺伝子検査内訳データ：アプリケーション別

世界の希少疾患遺伝子検査の市場規模実績：アプリケーション別 (2017-2022)
世界の希少疾患遺伝子検査の市場規模予測：アプリケーション別 (2023-2028)

第6章北米

北米の希少疾患遺伝子検査市場規模 (2017-2028)
北米の希少疾患遺伝子検査市場規模：タイプ別
- 北米の希少疾患遺伝子検査市場規模：タイプ別 (2017-2022)
- 北米の希少疾患遺伝子検査市場規模：タイプ別 (2023-2028)
- 北米の希少疾患遺伝子検査の市場シェア：タイプ別 (2017-2028)
北米の希少疾患遺伝子検査市場規模：アプリケーション別
- 北米の希少疾患遺伝子検査市場規模：アプリケーション別 (2017-2022)
- 北米の希少疾患遺伝子検査市場規模：アプリケーション別 (2023-2028)
- 北米の希少疾患遺伝子検査の市場シェア：アプリケーション別 (2017-2028)
北米の希少疾患遺伝子検査市場規模：国別
- 北米の希少疾患遺伝子検査市場規模：国別 (2017-2022)
- 北米の希少疾患遺伝子検査市場規模：国別 (2023-2028)
- 米国
- カナダ

第7章欧州

欧州の希少疾患遺伝子検査市場規模 (2017-2028)
欧州の希少疾患遺伝子検査市場規模：タイプ別
- 欧州の希少疾患遺伝子検査市場規模：タイプ別 (2017-2022)
- 欧州の希少疾患遺伝子検査市場規模：タイプ別 (2023-2028)
- 欧州の希少疾患遺伝子検査の市場シェア：タイプ別 (2017-2028)
欧州の希少疾患遺伝子検査市場規模：アプリケーション別
- 欧州の希少疾患遺伝子検査市場規模：アプリケーション別 (2017-2022)
- 欧州の希少疾患遺伝子検査市場規模：アプリケーション別 (2023-2028)
- 欧州の希少疾患遺伝子検査の市場シェア：アプリケーション別 (2017-2028)
欧州の希少疾患遺伝子検査市場規模：国別
- 欧州の希少疾患遺伝子検査市場規模：国別 (2017-2022)
- 欧州の希少疾患遺伝子検査市場規模：国別 (2023-2028)
- ドイツ
- フランス
- 英国
- イタリア
- ロシア
- 北欧

第8章アジア太平洋地域

アジア太平洋地域希少疾患遺伝子検査市場規模 (2017-2028)
アジア太平洋地域希少疾患遺伝子検査市場規模：タイプ別
- アジア太平洋地域希少疾患遺伝子検査市場規模：タイプ別 (2017-2022)
- アジア太平洋地域希少疾患遺伝子検査市場規模：タイプ別 (2023-2028)
- アジア太平洋地域希少疾患遺伝子検査の市場シェア：タイプ別 (2017-2028)
アジア太平洋地域希少疾患遺伝子検査市場規模：アプリケーション別
- アジア太平洋地域希少疾患遺伝子検査市場規模：アプリケーション別 (2017-2022)
- アジア太平洋地域希少疾患遺伝子検査市場規模：アプリケーション別 (2023-2028)
- アジア太平洋地域希少疾患遺伝子検査の市場シェア：アプリケーション別 (2017-2028)
アジア太平洋地域希少疾患遺伝子検査市場規模：地域別
- アジア太平洋地域希少疾患遺伝子検査市場規模：地域別 (2017-2022)
- アジア太平洋地域希少疾患遺伝子検査市場規模：地域別 (2023-2028)
- 中国
- 日本
- 韓国
- 東南アジア
- インド
- オーストラリア

第9章ラテンアメリカ

ラテンアメリカの希少疾患遺伝子検査市場規模 (2017-2028)
ラテンアメリカの希少疾患遺伝子検査市場規模：タイプ別
- ラテンアメリカの希少疾患遺伝子検査市場規模：タイプ別 (2017-2022)
- ラテンアメリカの希少疾患遺伝子検査市場規模：タイプ別 (2023-2028)
- ラテンアメリカの希少疾患遺伝子検査の市場シェア：タイプ別 (2017-2028)
ラテンアメリカの希少疾患遺伝子検査市場規模：アプリケーション別
- ラテンアメリカの希少疾患遺伝子検査市場規模：アプリケーション別 (2017-2022)
- ラテンアメリカの希少疾患遺伝子検査市場規模：アプリケーション別 (2023-2028)
- ラテンアメリカの希少疾患遺伝子検査の市場シェア：アプリケーション別 (2017-2028)
ラテンアメリカの希少疾患遺伝子検査市場規模：国別
- ラテンアメリカの希少疾患遺伝子検査市場規模：国別 (2017-2022)
- ラテンアメリカの希少疾患遺伝子検査市場規模：国別 (2023-2028)
- メキシコ
- ブラジル

第10章中東・アフリカ

中東・アフリカの希少疾患遺伝子検査市場規模 (2017-2028)
中東・アフリカの希少疾患遺伝子検査市場規模：タイプ別
- 中東・アフリカの希少疾患遺伝子検査市場規模：タイプ別 (2017-2022)
- 中東・アフリカの希少疾患遺伝子検査市場規模：タイプ別 (2023-2028)
- 中東・アフリカの希少疾患遺伝子検査の市場シェア：タイプ別 (2017-2028)
中東・アフリカの希少疾患遺伝子検査市場規模：アプリケーション別
- 中東・アフリカの希少疾患遺伝子検査市場規模：アプリケーション別 (2017-2022)
- 中東・アフリカの希少疾患遺伝子検査市場規模：アプリケーション別 (2023-2028)
- 中東・アフリカの希少疾患遺伝子検査の市場シェア：アプリケーション別 (2017-2028)
中東・アフリカの希少疾患遺伝子検査市場規模：国別
- 中東・アフリカの希少疾患遺伝子検査市場規模：国別 (2017-2022)
- 中東・アフリカの希少疾患遺伝子検査市場規模：国別 (2023-2028)
- トルコ
- サウジアラビア
- UAE

第11章主要企業のプロファイル

Quest Diagnostics
Centogene
Invitae Corporation
3billion
Arup Laboratories
Eurofins Scientific
Strand Life Sciences
Ambry Genetics
Perkin Elmer
Macrogen
Baylor Genetics
Color Genomics
Preventiongenetics
Progenity
Coopersurgical
Fulgent Genetics
Myriad Genetics
LabCorp
Opko Health

第12章アナリストによる分析/結論

第13章付録

図表

Table 1. Global Rare Disease Genetic Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Next-Generation Sequencing (NGS)
Table 3. Key Players of Array Technology
Table 4. Key Players of PCR-based Testing
Table 5. Key Players of Fluorescence in Situ Hybridization (FISH)
Table 6. Key Players of Sanger Sequencing
Table 7. Key Players of Karyotyping
Table 8. Key Players of Others
Table 9. Global Rare Disease Genetic Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 10. Global Rare Disease Genetic Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Rare Disease Genetic Testing Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Rare Disease Genetic Testing Market Share by Region (2017-2022)
Table 13. Global Rare Disease Genetic Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Rare Disease Genetic Testing Market Share by Region (2023-2028)
Table 15. Rare Disease Genetic Testing Market Trends
Table 16. Rare Disease Genetic Testing Market Drivers
Table 17. Rare Disease Genetic Testing Market Challenges
Table 18. Rare Disease Genetic Testing Market Restraints
Table 19. Global Rare Disease Genetic Testing Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Rare Disease Genetic Testing Revenue Share by Players (2017-2022)
Table 21. Global Top Rare Disease Genetic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Disease Genetic Testing as of 2021)
Table 22. Ranking of Global Top Rare Disease Genetic Testing Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Rare Disease Genetic Testing Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Rare Disease Genetic Testing Product Solution and Service
Table 26. Date of Enter into Rare Disease Genetic Testing Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Rare Disease Genetic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Rare Disease Genetic Testing Revenue Market Share by Type (2017-2022)
Table 30. Global Rare Disease Genetic Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Rare Disease Genetic Testing Revenue Market Share by Type (2023-2028)
Table 32. Global Rare Disease Genetic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Rare Disease Genetic Testing Revenue Share by Application (2017-2022)
Table 34. Global Rare Disease Genetic Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Rare Disease Genetic Testing Revenue Share by Application (2023-2028)
Table 36. North America Rare Disease Genetic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 37. North America Rare Disease Genetic Testing Market Size by Type (2023-2028) & (US$ Million)
Table 38. North America Rare Disease Genetic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 39. North America Rare Disease Genetic Testing Market Size by Application (2023-2028) & (US$ Million)
Table 40. North America Rare Disease Genetic Testing Market Size by Country (2017-2022) & (US$ Million)
Table 41. North America Rare Disease Genetic Testing Market Size by Country (2023-2028) & (US$ Million)
Table 42. Europe Rare Disease Genetic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 43. Europe Rare Disease Genetic Testing Market Size by Type (2023-2028) & (US$ Million)
Table 44. Europe Rare Disease Genetic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 45. Europe Rare Disease Genetic Testing Market Size by Application (2023-2028) & (US$ Million)
Table 46. Europe Rare Disease Genetic Testing Market Size by Country (2017-2022) & (US$ Million)
Table 47. Europe Rare Disease Genetic Testing Market Size by Country (2023-2028) & (US$ Million)
Table 48. Asia Pacific Rare Disease Genetic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 49. Asia Pacific Rare Disease Genetic Testing Market Size by Type (2023-2028) & (US$ Million)
Table 50. Asia Pacific Rare Disease Genetic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 51. Asia Pacific Rare Disease Genetic Testing Market Size by Application (2023-2028) & (US$ Million)
Table 52. Asia Pacific Rare Disease Genetic Testing Market Size by Region (2017-2022) & (US$ Million)
Table 53. Asia Pacific Rare Disease Genetic Testing Market Size by Region (2023-2028) & (US$ Million)
Table 54. Latin America Rare Disease Genetic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 55. Latin America Rare Disease Genetic Testing Market Size by Type (2023-2028) & (US$ Million)
Table 56. Latin America Rare Disease Genetic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 57. Latin America Rare Disease Genetic Testing Market Size by Application (2023-2028) & (US$ Million)
Table 58. Latin America Rare Disease Genetic Testing Market Size by Country (2017-2022) & (US$ Million)
Table 59. Latin America Rare Disease Genetic Testing Market Size by Country (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Rare Disease Genetic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Rare Disease Genetic Testing Market Size by Type (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Rare Disease Genetic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Rare Disease Genetic Testing Market Size by Application (2023-2028) & (US$ Million)
Table 64. Middle East and Africa Rare Disease Genetic Testing Market Size by Country (2017-2022) & (US$ Million)
Table 65. Middle East and Africa Rare Disease Genetic Testing Market Size by Country (2023-2028) & (US$ Million)
Table 66. Quest Diagnostics Company Details
Table 67. Quest Diagnostics Business Overview
Table 68. Quest Diagnostics Rare Disease Genetic Testing Product
Table 69. Quest Diagnostics Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 70. Quest Diagnostics Recent Developments
Table 71. Centogene Company Details
Table 72. Centogene Business Overview
Table 73. Centogene Rare Disease Genetic Testing Product
Table 74. Centogene Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 75. Centogene Recent Developments
Table 76. Invitae Corporation Company Details
Table 77. Invitae Corporation Business Overview
Table 78. Invitae Corporation Rare Disease Genetic Testing Product
Table 79. Invitae Corporation Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 80. Invitae Corporation Recent Developments
Table 81. 3billion Company Details
Table 82. 3billion Business Overview
Table 83. 3billion Rare Disease Genetic Testing Product
Table 84. 3billion Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 85. 3billion Recent Developments
Table 86. Arup Laboratories Company Details
Table 87. Arup Laboratories Business Overview
Table 88. Arup Laboratories Rare Disease Genetic Testing Product
Table 89. Arup Laboratories Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 90. Arup Laboratories Recent Developments
Table 91. Eurofins Scientific Company Details
Table 92. Eurofins Scientific Business Overview
Table 93. Eurofins Scientific Rare Disease Genetic Testing Product
Table 94. Eurofins Scientific Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 95. Eurofins Scientific Recent Developments
Table 96. Strand Life Sciences Company Details
Table 97. Strand Life Sciences Business Overview
Table 98. Strand Life Sciences Rare Disease Genetic Testing Product
Table 99. Strand Life Sciences Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 100. Strand Life Sciences Recent Developments
Table 101. Ambry Genetics Company Details
Table 102. Ambry Genetics Business Overview
Table 103. Ambry Genetics Rare Disease Genetic Testing Product
Table 104. Ambry Genetics Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 105. Ambry Genetics Recent Developments
Table 106. Perkin Elmer Company Details
Table 107. Perkin Elmer Business Overview
Table 108. Perkin Elmer Rare Disease Genetic Testing Product
Table 109. Perkin Elmer Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 110. Perkin Elmer Recent Developments
Table 111. Macrogen Company Details
Table 112. Macrogen Business Overview
Table 113. Macrogen Rare Disease Genetic Testing Product
Table 114. Macrogen Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 115. Macrogen Recent Developments
Table 116. Baylor Genetics Company Details
Table 117. Baylor Genetics Business Overview
Table 118. Baylor Genetics Rare Disease Genetic Testing Product
Table 119. Baylor Genetics Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 120. Baylor Genetics Recent Developments
Table 121. Color Genomics Company Details
Table 122. Color Genomics Business Overview
Table 123. Color Genomics Rare Disease Genetic Testing Product
Table 124. Color Genomics Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 125. Color Genomics Recent Developments
Table 126. Preventiongenetics Company Details
Table 127. Preventiongenetics Business Overview
Table 128. Preventiongenetics Rare Disease Genetic Testing Product
Table 129. Preventiongenetics Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 130. Preventiongenetics Recent Developments
Table 131. Progenity Company Details
Table 132. Progenity Business Overview
Table 133. Progenity Rare Disease Genetic Testing Product
Table 134. Progenity Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 135. Progenity Recent Developments
Table 136. Coopersurgical Company Details
Table 137. Coopersurgical Business Overview
Table 138. Coopersurgical Rare Disease Genetic Testing Product
Table 139. Coopersurgical Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 140. Coopersurgical Recent Developments
Table 141. Fulgent Genetics Company Details
Table 142. Fulgent Genetics Business Overview
Table 143. Fulgent Genetics Rare Disease Genetic Testing Product
Table 144. Fulgent Genetics Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 145. Fulgent Genetics Recent Developments
Table 146. Myriad Genetics Company Details
Table 147. Myriad Genetics Business Overview
Table 148. Myriad Genetics Rare Disease Genetic Testing Product
Table 149. Myriad Genetics Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 150. Myriad Genetics Recent Developments
Table 151. LabCorp Company Details
Table 152. LabCorp Business Overview
Table 153. LabCorp Rare Disease Genetic Testing Product
Table 154. LabCorp Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 155. LabCorp Recent Developments
Table 156. Opko Health Company Details
Table 157. Opko Health Business Overview
Table 158. Opko Health Rare Disease Genetic Testing Product
Table 159. Opko Health Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 160. Opko Health Recent Developments
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Rare Disease Genetic Testing Market Share by Type: 2021 VS 2028
Figure 2. Next-Generation Sequencing (NGS) Features
Figure 3. Array Technology Features
Figure 4. PCR-based Testing Features
Figure 5. Fluorescence in Situ Hybridization (FISH) Features
Figure 6. Sanger Sequencing Features
Figure 7. Karyotyping Features
Figure 8. Others Features
Figure 9. Global Rare Disease Genetic Testing Market Share by Application: 2021 VS 2028
Figure 10. Research Laboratories and CROs Case Studies
Figure 11. Diagnostic Laboratories Case Studies
Figure 12. Hospitals and Clinics Case Studies
Figure 13. Others Case Studies
Figure 14. Rare Disease Genetic Testing Report Years Considered
Figure 15. Global Rare Disease Genetic Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 16. Global Rare Disease Genetic Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Rare Disease Genetic Testing Market Share by Region: 2021 VS 2028
Figure 18. Global Rare Disease Genetic Testing Market Share by Players in 2021
Figure 19. Global Top Rare Disease Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Disease Genetic Testing as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Rare Disease Genetic Testing Revenue in 2021
Figure 21. North America Rare Disease Genetic Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 22. North America Rare Disease Genetic Testing Market Size Market Share by Type (2017-2028)
Figure 23. North America Rare Disease Genetic Testing Market Size Market Share by Application (2017-2028)
Figure 24. North America Rare Disease Genetic Testing Market Size Share by Country (2017-2028)
Figure 25. United States Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Canada Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe Rare Disease Genetic Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 28. Europe Rare Disease Genetic Testing Market Size Market Share by Type (2017-2028)
Figure 29. Europe Rare Disease Genetic Testing Market Size Market Share by Application (2017-2028)
Figure 30. Europe Rare Disease Genetic Testing Market Size Share by Country (2017-2028)
Figure 31. Germany Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. France Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. U.K. Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Italy Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Russia Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Nordic Countries Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Rare Disease Genetic Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 38. Asia Pacific Rare Disease Genetic Testing Market Size Market Share by Type (2017-2028)
Figure 39. Asia Pacific Rare Disease Genetic Testing Market Size Market Share by Application (2017-2028)
Figure 40. Asia Pacific Rare Disease Genetic Testing Market Size Share by Region (2017-2028)
Figure 41. China Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Japan Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. South Korea Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Southeast Asia Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. India Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Australia Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 47. Latin America Rare Disease Genetic Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Latin America Rare Disease Genetic Testing Market Size Market Share by Type (2017-2028)
Figure 49. Latin America Rare Disease Genetic Testing Market Size Market Share by Application (2017-2028)
Figure 50. Latin America Rare Disease Genetic Testing Market Size Share by Country (2017-2028)
Figure 51. Mexico Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Brazil Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Middle East & Africa Rare Disease Genetic Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 54. Middle East and Africa Rare Disease Genetic Testing Market Size Market Share by Type (2017-2028)
Figure 55. Middle East and Africa Rare Disease Genetic Testing Market Size Market Share by Application (2017-2028)
Figure 56. Middle East and Africa Rare Disease Genetic Testing Market Size Share by Country (2017-2028)
Figure 57. Turkey Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Saudi Arabia Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. UAE Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 60. Quest Diagnostics Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 61. Centogene Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 62. Invitae Corporation Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 63. 3billion Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 64. Arup Laboratories Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 65. Eurofins Scientific Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 66. Strand Life Sciences Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 67. Ambry Genetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 68. Perkin Elmer Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 69. Macrogen Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 70. Baylor Genetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 71. Color Genomics Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 72. Preventiongenetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 73. Progenity Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 74. Coopersurgical Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 75. Fulgent Genetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 76. Myriad Genetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 77. LabCorp Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 78. Opko Health Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed

This research report focuses on the Rare Disease Genetic Testing Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

1 Report Business Overview

1.1 Study Scope
1.2 Market Analysis by Type
- 1.2.1 Global Rare Disease Genetic Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Next-Generation Sequencing (NGS)
- 1.2.3 Array Technology
- 1.2.4 PCR-based Testing
- 1.2.5 Fluorescence in Situ Hybridization (FISH)
- 1.2.6 Sanger Sequencing
- 1.2.7 Karyotyping
- 1.2.8 Others
1.3 Market by Application
- 1.3.1 Global Rare Disease Genetic Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Research Laboratories and CROs
- 1.3.3 Diagnostic Laboratories
- 1.3.4 Hospitals and Clinics
- 1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends

2.1 Global Rare Disease Genetic Testing Market Perspective (2017-2028)
2.2 Rare Disease Genetic Testing Growth Trends by Region
- 2.2.1 Rare Disease Genetic Testing Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Rare Disease Genetic Testing Historic Market Size by Region (2017-2022)
- 2.2.3 Rare Disease Genetic Testing Forecasted Market Size by Region (2023-2028)
2.3 Rare Disease Genetic Testing Market Dynamics
- 2.3.1 Rare Disease Genetic Testing Industry Trends
- 2.3.2 Rare Disease Genetic Testing Market Drivers
- 2.3.3 Rare Disease Genetic Testing Market Challenges
- 2.3.4 Rare Disease Genetic Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Rare Disease Genetic Testing Players by Revenue
- 3.1.1 Global Top Rare Disease Genetic Testing Players by Revenue (2017-2022)
- 3.1.2 Global Rare Disease Genetic Testing Revenue Market Share by Players (2017-2022)
3.2 Global Rare Disease Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rare Disease Genetic Testing Revenue
3.4 Global Rare Disease Genetic Testing Market Concentration Ratio
- 3.4.1 Global Rare Disease Genetic Testing Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Rare Disease Genetic Testing Revenue in 2021
3.5 Rare Disease Genetic Testing Key Players Head office and Area Served
3.6 Key Players Rare Disease Genetic Testing Product Solution and Service
3.7 Date of Enter into Rare Disease Genetic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Rare Disease Genetic Testing Breakdown Data by Type

4.1 Global Rare Disease Genetic Testing Historic Market Size by Type (2017-2022)
4.2 Global Rare Disease Genetic Testing Forecasted Market Size by Type (2023-2028)

5 Rare Disease Genetic Testing Breakdown Data by Application

5.1 Global Rare Disease Genetic Testing Historic Market Size by Application (2017-2022)
5.2 Global Rare Disease Genetic Testing Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Rare Disease Genetic Testing Market Size (2017-2028)
6.2 North America Rare Disease Genetic Testing Market Size by Type
- 6.2.1 North America Rare Disease Genetic Testing Market Size by Type (2017-2022)
- 6.2.2 North America Rare Disease Genetic Testing Market Size by Type (2023-2028)
- 6.2.3 North America Rare Disease Genetic Testing Market Share by Type (2017-2028)
6.3 North America Rare Disease Genetic Testing Market Size by Application
- 6.3.1 North America Rare Disease Genetic Testing Market Size by Application (2017-2022)
- 6.3.2 North America Rare Disease Genetic Testing Market Size by Application (2023-2028)
- 6.3.3 North America Rare Disease Genetic Testing Market Share by Application (2017-2028)
6.4 North America Rare Disease Genetic Testing Market Size by Country
- 6.4.1 North America Rare Disease Genetic Testing Market Size by Country (2017-2022)
- 6.4.2 North America Rare Disease Genetic Testing Market Size by Country (2023-2028)
- 6.4.3 United States
- 6.4.4 Canada

7 Europe

7.1 Europe Rare Disease Genetic Testing Market Size (2017-2028)
7.2 Europe Rare Disease Genetic Testing Market Size by Type
- 7.2.1 Europe Rare Disease Genetic Testing Market Size by Type (2017-2022)
- 7.2.2 Europe Rare Disease Genetic Testing Market Size by Type (2023-2028)
- 7.2.3 Europe Rare Disease Genetic Testing Market Share by Type (2017-2028)
7.3 Europe Rare Disease Genetic Testing Market Size by Application
- 7.3.1 Europe Rare Disease Genetic Testing Market Size by Application (2017-2022)
- 7.3.2 Europe Rare Disease Genetic Testing Market Size by Application (2023-2028)
- 7.3.3 Europe Rare Disease Genetic Testing Market Share by Application (2017-2028)
7.4 Europe Rare Disease Genetic Testing Market Size by Country
- 7.4.1 Europe Rare Disease Genetic Testing Market Size by Country (2017-2022)
- 7.4.2 Europe Rare Disease Genetic Testing Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Rare Disease Genetic Testing Market Size (2017-2028)
8.2 Asia-Pacific Rare Disease Genetic Testing Market Size by Type
- 8.2.1 Asia-Pacific Rare Disease Genetic Testing Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific Rare Disease Genetic Testing Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific Rare Disease Genetic Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Rare Disease Genetic Testing Market Size by Application
- 8.3.1 Asia-Pacific Rare Disease Genetic Testing Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific Rare Disease Genetic Testing Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific Rare Disease Genetic Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Rare Disease Genetic Testing Market Size by Region
- 8.4.1 Asia-Pacific Rare Disease Genetic Testing Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific Rare Disease Genetic Testing Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia

9 Latin America

9.1 Latin America Rare Disease Genetic Testing Market Size (2017-2028)
9.2 Latin America Rare Disease Genetic Testing Market Size by Type
- 9.2.1 Latin America Rare Disease Genetic Testing Market Size by Type (2017-2022)
- 9.2.2 Latin America Rare Disease Genetic Testing Market Size by Type (2023-2028)
- 9.2.3 Latin America Rare Disease Genetic Testing Market Share by Type (2017-2028)
9.3 Latin America Rare Disease Genetic Testing Market Size by Application
- 9.3.1 Latin America Rare Disease Genetic Testing Market Size by Application (2017-2022)
- 9.3.2 Latin America Rare Disease Genetic Testing Market Size by Application (2023-2028)
- 9.3.3 Latin America Rare Disease Genetic Testing Market Share by Application (2017-2028)
9.4 Latin America Rare Disease Genetic Testing Market Size by Country
- 9.4.1 Latin America Rare Disease Genetic Testing Market Size by Country (2017-2022)
- 9.4.2 Latin America Rare Disease Genetic Testing Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Rare Disease Genetic Testing Market Size (2017-2028)
10.2 Middle East & Africa Rare Disease Genetic Testing Market Size by Type
- 10.2.1 Middle East & Africa Rare Disease Genetic Testing Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa Rare Disease Genetic Testing Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa Rare Disease Genetic Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Rare Disease Genetic Testing Market Size by Application
- 10.3.1 Middle East & Africa Rare Disease Genetic Testing Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa Rare Disease Genetic Testing Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa Rare Disease Genetic Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Rare Disease Genetic Testing Market Size by Country
- 10.4.1 Middle East & Africa Rare Disease Genetic Testing Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa Rare Disease Genetic Testing Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE

11 Key Players Profiles

11.1 Quest Diagnostics
- 11.1.1 Quest Diagnostics Company Details
- 11.1.2 Quest Diagnostics Business Overview
- 11.1.3 Quest Diagnostics Rare Disease Genetic Testing Introduction
- 11.1.4 Quest Diagnostics Revenue in Rare Disease Genetic Testing Business (2017-2022)
- 11.1.5 Quest Diagnostics Recent Developments
11.2 Centogene
- 11.2.1 Centogene Company Details
- 11.2.2 Centogene Business Overview
- 11.2.3 Centogene Rare Disease Genetic Testing Introduction
- 11.2.4 Centogene Revenue in Rare Disease Genetic Testing Business (2017-2022)
- 11.2.5 Centogene Recent Developments
11.3 Invitae Corporation
- 11.3.1 Invitae Corporation Company Details
- 11.3.2 Invitae Corporation Business Overview
- 11.3.3 Invitae Corporation Rare Disease Genetic Testing Introduction
- 11.3.4 Invitae Corporation Revenue in Rare Disease Genetic Testing Business (2017-2022)
- 11.3.5 Invitae Corporation Recent Developments
11.4 3billion
- 11.4.1 3billion Company Details
- 11.4.2 3billion Business Overview
- 11.4.3 3billion Rare Disease Genetic Testing Introduction
- 11.4.4 3billion Revenue in Rare Disease Genetic Testing Business (2017-2022)
- 11.4.5 3billion Recent Developments
11.5 Arup Laboratories
- 11.5.1 Arup Laboratories Company Details
- 11.5.2 Arup Laboratories Business Overview
- 11.5.3 Arup Laboratories Rare Disease Genetic Testing Introduction
- 11.5.4 Arup Laboratories Revenue in Rare Disease Genetic Testing Business (2017-2022)
- 11.5.5 Arup Laboratories Recent Developments
11.6 Eurofins Scientific
- 11.6.1 Eurofins Scientific Company Details
- 11.6.2 Eurofins Scientific Business Overview
- 11.6.3 Eurofins Scientific Rare Disease Genetic Testing Introduction
- 11.6.4 Eurofins Scientific Revenue in Rare Disease Genetic Testing Business (2017-2022)
- 11.6.5 Eurofins Scientific Recent Developments
11.7 Strand Life Sciences
- 11.7.1 Strand Life Sciences Company Details
- 11.7.2 Strand Life Sciences Business Overview
- 11.7.3 Strand Life Sciences Rare Disease Genetic Testing Introduction
- 11.7.4 Strand Life Sciences Revenue in Rare Disease Genetic Testing Business (2017-2022)
- 11.7.5 Strand Life Sciences Recent Developments
11.8 Ambry Genetics
- 11.8.1 Ambry Genetics Company Details
- 11.8.2 Ambry Genetics Business Overview
- 11.8.3 Ambry Genetics Rare Disease Genetic Testing Introduction
- 11.8.4 Ambry Genetics Revenue in Rare Disease Genetic Testing Business (2017-2022)
- 11.8.5 Ambry Genetics Recent Developments
11.9 Perkin Elmer
- 11.9.1 Perkin Elmer Company Details
- 11.9.2 Perkin Elmer Business Overview
- 11.9.3 Perkin Elmer Rare Disease Genetic Testing Introduction
- 11.9.4 Perkin Elmer Revenue in Rare Disease Genetic Testing Business (2017-2022)
- 11.9.5 Perkin Elmer Recent Developments
11.10 Macrogen
- 11.10.1 Macrogen Company Details
- 11.10.2 Macrogen Business Overview
- 11.10.3 Macrogen Rare Disease Genetic Testing Introduction
- 11.10.4 Macrogen Revenue in Rare Disease Genetic Testing Business (2017-2022)
- 11.10.5 Macrogen Recent Developments
11.11 Baylor Genetics
- 11.11.1 Baylor Genetics Company Details
- 11.11.2 Baylor Genetics Business Overview
- 11.11.3 Baylor Genetics Rare Disease Genetic Testing Introduction
- 11.11.4 Baylor Genetics Revenue in Rare Disease Genetic Testing Business (2017-2022)
- 11.11.5 Baylor Genetics Recent Developments
11.12 Color Genomics
- 11.12.1 Color Genomics Company Details
- 11.12.2 Color Genomics Business Overview
- 11.12.3 Color Genomics Rare Disease Genetic Testing Introduction
- 11.12.4 Color Genomics Revenue in Rare Disease Genetic Testing Business (2017-2022)
- 11.12.5 Color Genomics Recent Developments
11.13 Preventiongenetics
- 11.13.1 Preventiongenetics Company Details
- 11.13.2 Preventiongenetics Business Overview
- 11.13.3 Preventiongenetics Rare Disease Genetic Testing Introduction
- 11.13.4 Preventiongenetics Revenue in Rare Disease Genetic Testing Business (2017-2022)
- 11.13.5 Preventiongenetics Recent Developments
11.14 Progenity
- 11.14.1 Progenity Company Details
- 11.14.2 Progenity Business Overview
- 11.14.3 Progenity Rare Disease Genetic Testing Introduction
- 11.14.4 Progenity Revenue in Rare Disease Genetic Testing Business (2017-2022)
- 11.14.5 Progenity Recent Developments
11.15 Coopersurgical
- 11.15.1 Coopersurgical Company Details
- 11.15.2 Coopersurgical Business Overview
- 11.15.3 Coopersurgical Rare Disease Genetic Testing Introduction
- 11.15.4 Coopersurgical Revenue in Rare Disease Genetic Testing Business (2017-2022)
- 11.15.5 Coopersurgical Recent Developments
11.16 Fulgent Genetics
- 11.16.1 Fulgent Genetics Company Details
- 11.16.2 Fulgent Genetics Business Overview
- 11.16.3 Fulgent Genetics Rare Disease Genetic Testing Introduction
- 11.16.4 Fulgent Genetics Revenue in Rare Disease Genetic Testing Business (2017-2022)
- 11.16.5 Fulgent Genetics Recent Developments
11.17 Myriad Genetics
- 11.17.1 Myriad Genetics Company Details
- 11.17.2 Myriad Genetics Business Overview
- 11.17.3 Myriad Genetics Rare Disease Genetic Testing Introduction
- 11.17.4 Myriad Genetics Revenue in Rare Disease Genetic Testing Business (2017-2022)
- 11.17.5 Myriad Genetics Recent Developments
11.18 LabCorp
- 11.18.1 LabCorp Company Details
- 11.18.2 LabCorp Business Overview
- 11.18.3 LabCorp Rare Disease Genetic Testing Introduction
- 11.18.4 LabCorp Revenue in Rare Disease Genetic Testing Business (2017-2022)
- 11.18.5 LabCorp Recent Developments
11.19 Opko Health
- 11.19.1 Opko Health Company Details
- 11.19.2 Opko Health Business Overview
- 11.19.3 Opko Health Rare Disease Genetic Testing Introduction
- 11.19.4 Opko Health Revenue in Rare Disease Genetic Testing Business (2017-2022)
- 11.19.5 Opko Health Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

世界の希少疾患遺伝子検査市場：考察と予測 (2028年まで)

Global Rare Disease Genetic Testing Market Insights, Forecast to 2028

目次

第1章レポート概要

第2章世界の市場成長トレンド

第3章競合情勢：主要企業別

第4章希少疾患遺伝子検査内訳データ：タイプ別

第5章希少疾患遺伝子検査内訳データ：アプリケーション別

第6章北米

第7章欧州

第8章アジア太平洋地域

第9章ラテンアメリカ

第10章中東・アフリカ

第11章主要企業のプロファイル

第12章アナリストによる分析/結論

第13章付録

List of Figures

List of Figures

TABLE OF CONTENTS

1 Report Business Overview

2 Global Growth Trends

3 Competition Landscape by Key Players

4 Rare Disease Genetic Testing Breakdown Data by Type

5 Rare Disease Genetic Testing Breakdown Data by Application

6 North America

7 Europe

8 Asia-Pacific

9 Latin America

10 Middle East & Africa

11 Key Players Profiles

12 Analyst's Viewpoints/Conclusions

13 Appendix

世界の希少疾患遺伝子検査市場：考察と予測 (2028年まで)

Global Rare Disease Genetic Testing Market Insights, Forecast to 2028

目次

第1章 レポート概要

第2章 世界の市場成長トレンド

第3章 競合情勢：主要企業別

第4章 希少疾患遺伝子検査 内訳データ：タイプ別

第5章 希少疾患遺伝子検査 内訳データ：アプリケーション別

第6章 北米

第7章 欧州

第8章 アジア太平洋地域

第9章 ラテンアメリカ

第10章 中東・アフリカ

第11章 主要企業のプロファイル

第12章 アナリストによる分析/結論

第13章 付録

List of Figures

List of Figures

TABLE OF CONTENTS

1 Report Business Overview

2 Global Growth Trends

3 Competition Landscape by Key Players

4 Rare Disease Genetic Testing Breakdown Data by Type

5 Rare Disease Genetic Testing Breakdown Data by Application

6 North America

7 Europe

8 Asia-Pacific

9 Latin America

10 Middle East & Africa

11 Key Players Profiles

12 Analyst's Viewpoints/Conclusions

13 Appendix

第1章レポート概要

第2章世界の市場成長トレンド

第3章競合情勢：主要企業別

第4章希少疾患遺伝子検査内訳データ：タイプ別

第5章希少疾患遺伝子検査内訳データ：アプリケーション別

第6章北米

第7章欧州

第8章アジア太平洋地域

第9章ラテンアメリカ

第10章中東・アフリカ

第11章主要企業のプロファイル

第12章アナリストによる分析/結論

第13章付録